Bilde av Melberg, Hans Olav
Bilde av Melberg, Hans Olav
Department of Community Medicine hans.o.melberg@uit.no +4777649162 Tromsø MH L10.146

Hans Olav Melberg


Professor, Health economics and health services research, Leader of Health Services Research Group


  • Mirabella Zhao, Sandre Svatun Lirhus, Mikael Lördal, Ebbe Langholz, Torben Knudsen, Markku Voutilainen et al.:
    Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway
    Alimentary Pharmacology and Therapeutics 2022 DOI
  • Kristina Malene Ødegaard, Sandre Svatun Lirhus, Hans Olav Melberg, Jonas Hallen, Sigrun Halvorsen :
    A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates
    BMC Cardiovascular Disorders 2022 ARKIV / DOI
  • Kristina Malene Ødegaard, Sandre Svatun Lirhus, Hans Olav Melberg, Jonas Hallen, Sigrun Halvorsen :
    Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014–2020
    ESC Heart Failure 2022 ARKIV / DOI
  • Christoffer Bugge, Stein Kaasa, Erik Magnus Sæther, Hans Olav Melberg, Ivar Sønbø Kristiansen :
    What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
    BMJ Open 2021 DOI
  • Snorre Kverndokk, Hans Olav Melberg :
    Using fees to reduce bed-blocking: a game between hospitals and long-term care providers
    European Journal of Health Economics 2021 OMTALE / DOI
  • Karoline Anisdahl, Sandre Svatun Lirhus, Asle Wilhelm Medhus, Bjørn Moum, Hans Olav Melberg, Marte Lie Høivik :
    First-line biologic treatment of inflammatory bowel disease during the first 12 months after diagnosis from 2010 to 2016: a Norwegian nationwide registry study
    Scandinavian Journal of Gastroenterology 2021 ARKIV / DOI
  • Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum, Karoline Anisdahl, Hans Olav Melberg :
    Incidence and prevalence of inflammatory bowel disease in norway and the impact of different case definitions: A nationwide registry study
    Clinical Epidemiology 2021 ARKIV / DOI
  • Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg :
    Factors associated with the persistence of oral 5-aminosalicylic acid monotherapy in ulcerative colitis: a nationwide Norwegian cohort study
    Therapeutic Advances in Gastroenterology 2021 ARKIV / DOI
  • Kristina Malene Ødegaard, Jonas Hallen, Sandre Svatun Lirhus, Hans Olav Melberg, Sigrun Halvorsen :
    Incidence, prevalence, and mortality of heart failure: a nationwide registry study from 2013-2016
    ESC Heart Failure 2020 ARKIV / DOI
  • Lars Asphaug, Hans Olav Melberg :
    The Cost-Effectiveness of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in Norway
    Medical Decision Making Policy & Practice 2019 DOI
  • Lars Asphaug, Maja Thiele, Aleksander Krag, Hans Olav Melberg :
    Cost‐Effectiveness of Noninvasive Screening for Alcohol‐Related Liver Fibrosis
    Hepatology 2019 DOI
  • Hans Olav Melberg, Lars Asphaug :
    Health Economics and Fatty Liver Disease
    Springer Nature 2019 DOI
  • Camilla Beck Olsen, Hans Olav Melberg :
    Did adolescents in Norway respond to the elimination of copayments for general practitioner services?
    Health Economics 2018 ARKIV / DOI
  • Sandre Svatun Lirhus, Marte Lie Høivik, Bjørn Moum, Hans Olav Melberg :
    Regional differences in anti-TNF-a therapy and surgery in the treatment of inflammatory bowel disease patients: a Norwegian nationwide cohort study
    Scandinavian Journal of Gastroenterology 2018 ARKIV / DOI
  • Elin Kjelle, Linn Kleven, Hilde M Olerud, Hans Olav Melberg :
    Cost analysis of mobile radiography services for nursing home residents in Southeast Norway
    Journal of Evaluation In Clinical Practice 2018 ARKIV / DOI
  • Hans Olav Melberg :
    Samhandlingsreformen og kausal inferens
    Michael quarterly. Supplement 2017 ARKIV
  • Jan Blomqvist, Raitasalo Kirsimarja, Hans Olav Melberg, Dirk Schreckenberg, Christine Peschel, Justyna klingemann et al.:
    Popular images of addiction in five European countries
    Oxford University Press 2016 DOI
  • Trygve Ottersen, Reidun Førde, Meetali Kakad, Alice Kjellevold, Hans Olav Melberg, Atle Moen et al.:
    A new proposal for priority setting in Norway: Open and fair
    Health Policy 2016 DOI
  • Justin E. Bekelman, Scott D. Halpern, Carl Rudolf Blankart, Julie P. Bynum, Joachim Cohen, Robert Fowler et al.:
    Comparison of site of death, health care utilization, and hospital expenditures for patients dying With cancer in 7 developed countries
    Journal of the American Medical Association (JAMA) 2016 DOI
  • Camilla Beck Olsen, Hans Olav Melberg :
    Påvirker egenandeler ungdoms legebesøk?
    Tidsskrift for velferdsforskning 2016 ARKIV / DOI
  • Hans Olav Melberg, Camilla Beck Olsen, Kine Pedersen :
    Did hospitals respond to changes in weights of Diagnosis Related Groups in Norway between 2006 and 2013?
    Health Policy 2016 DOI
  • Terje P. Hagen, Hans Olav Melberg :
    Liggetider og reinnleggelser før og etter Samhandlingsreformen.
    Tidsskrift for omsorgsforskning 2016 DOI
  • Hans Olav Melberg, Ida Eriksen :
    The effects of introducing an electronic prescription system with no copayments
    Health Economics Review 2015 DOI
  • Emma Medin, Fanny Goude, Hans Olav Melberg, Fabrizio Tediosi, Eva Belicza, Mikko Peltola :
    European regional differences in all-cause mortality and length of stay for patients with hip fracture
    Health Economics 2015 DOI
  • Ida Eriksen, Hans Olav Melberg :
    Endringer over tid i legers holdninger til kostnader
    Akademika forlag 2014
  • Steinar Holden, Oona Borghild Dunlop, Styrk Fjærtoft Vik, Ingrid Hjort, Simen Markussen, Hans Olav Melberg et al.:
    Holden-IV (covid-19) Hovedrapport: Samfunnsøkonomiske vurderinger av smitteverntiltak
    2022
  • Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg :
    Forskjeller i medikamentoverlevelse mellom perorale mesalazin-preparater som monoterapi ved ulcerøs colitt
    2020
  • Reidar Fossmark, Maya Olaisen, Tom Christian Martinsen, Hans Olav Melberg :
    P760 Differences in persistence of oral mesalazine preparations as monotherapy in patients with ulcerative colitis
    Journal of Crohn's and Colitis 2020 DOI
  • Linda Hildegard Bergersen, Aasta Marie Bjorvand Bjørkøy, Evandro Fei Fang, Olav Gjelsvik, Lene Hystad Hove, Janicke Liaaen Jensen et al.:
    Vi må kunne tenke nytt om alderdom
    2020 FULLTEKST / DATA
  • Tore Tennøe, Hilde Lovett, Erik Fosse, Siri B Hatlen, Steinar Madsen, Damoun Nassehi et al.:
    Kunstig Intelligens og Norske Helsedata
    2019
  • Hans Olav Melberg :
    Value in health: How it is defined and used in priority setting and pricing in Norway
    HealthcarePapers 2019 DOI
  • Elin Kjelle, Linn Kleven, Hilde M Olerud, Hans Olav Melberg :
    Radiography on wheels for nursing home residents may reduce healthcare costs
    2018
  • Hans Olav Melberg :
    Helse-Norge trenger tvil – ikke bare heiarop
    Dagens medisin 09. March 2018
  • Hans Olav Melberg :
    Obama-reformen – og norsk helsepolitikk
    Dagens medisin 05. May 2018
  • Hans Olav Melberg :
    Hvorfor koster diamanter mer enn vann?
    Dagens medisin 2018
  • Hans Olav Melberg :
    Registertilgang i molboland?
    Dagens medisin 2018
  • Hilde Lovett, Damoun Nassehi, Erik Fosse, Siri B Hatlen, Steinar Madsen, Hans Olav Melberg et al.:
    Kunstig Intelligens - Muligheter, Utfordringer og en Plan for Norge
    2018
  • Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand, Thobias Gedde-Dahl et al.:
    Cost-utility of allogeneic hematopoietic stem cell transplantation in Norway
    Bone Marrow Transplantation 2018 DOI
  • Phoi Phoi Diep, Hans Olav Melberg, Lorentz Brinch, Jochen Buechner, Yngvar Fløisand, Thobias Gedde-Dahl et al.:
    Allogeneic hematopoietic stem cell transplantation in Norway 1974-2009: Cost-utility and survival in children and young adults
    2017
  • Hans Olav Melberg :
    Skal det være en app –eller to?
    Dagens medisin 18. January 2016
  • Hans Olav Melberg :
    Medisiner i ingenmannsland – mens tiden går…
    Dagens medisin 18. April 2016
  • Hilde Lovett, Tore Tennøe, Ola Dale, Nils Jørgen Langtvedt, Hans Olav Melberg, Steinar Madsen et al.:
    Mobile Selvtester
    2016
  • Hans Olav Melberg :
    Helse og finansiering i Norge
    2015
  • Hans Olav Melberg :
    Effekter av politiske reformer: Hvorfor går det ofte galt?
    2015
  • Hans Olav Melberg :
    Bruker vi de store pengene på de største problemene?
    2015
  • Hans Olav Melberg :
    Hellig helse - og prislapp på slutten av livet?
    Dagens medisin 10. March 2014 FULLTEKST
  • Hans Olav Melberg :
    Statsbudsjettet: Raskere og mer private symfonier
    Dagens medisin 27. October 2014 FULLTEKST
  • Hans Olav Melberg :
    Nye regler for prioritering
    2014
  • Hans Olav Melberg :
    Jordbær, finansiering - og informasjon i norsk helsevesen
    Dagens medisin 08. September 2014 FULLTEKST
  • Hans Olav Melberg :
    Struts, sykehjem og søppel?
    Dagens medisin 23. May 2014 DATA

  • The 50 latest publications is shown on this page. See all publications in Cristin here →


    Research interests

    I am broadly interested and engaged in various research questions within health economics and health services research. I particularly focus on how to utilize large registry data (such as the Norwegian Patient Registry, etc.) to answer questions such as: What is the impact of diseases on work ability? What is the effect of policy reforms and changes in reimbursement systems on healthcare consumption? How do hospitals and municipalities react to changes in financial incentives in healthcare, such as changes in the fee the municipality has to pay for patients who are ready for discharge but need to stay in the hospital? What is the proper balance between fixed salary and bonus-based financing systems?

    Teaching

    HEL 3007 Health Economics


    Member of research group